solid quarter organ highlight
strong solid organ growth acceler stack basi organ
actual calcul closer ahead consensu ub ep
ahead consensu report revenu ahead also
solid stack basi organ growth acceler highest record
adjust assum benefit recov last quarter data center impact
organ growth segment beat led growth life scienc solut
consensu lab product servic consensu specialti dx
consensu also beat analyt instrument came bit light
consensu light ebit margin miss segment ebit
margin line save lp bit short rais guidanc despit wors fx
impli revenu consensu ep shi
read across topic call
look detail geographies/custom esp china hi teen
biopharma ub estimate plu industri busi revenu
given investor increas concern macro china headlin
result well receiv
trade data key metric
compani account thomson reuter ub estim ub adjust ep state goodwill-rel charg adjust abnorm econom item analyst
judgement valuat base averag share price year base share price oct edt
report prepar ub secur llc analyst certif requir disclosur begin
page ub seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
valuat method risk statement
rais pt use ntm price-to-earnings vs current
assum continu organ growth plu success enabl slight
multipl expans pt support dcf
industry-wid risk includ declin spend pharmaceut compani
due signific declin fund small compani promin
trial failur affect class drug deceler global growth
includ risk escal trade tension pressur academ
govern budget could result recessionari cost-cut
polit chang price pressur diagnost sector due
protect access medicar act pama chang competit dynam
includ disrupt new entrant certain technolog inabl
compani compet effect china critic growth market foreign
exchang fluctuat chang tax polici
includ biopharma slow chines economi
risk
integr recent larg make bad strateg decis futur
report prepar ub secur llc affili ub ag ub ag subsidiari branch affili
refer herein ub
inform way ub manag conflict maintain independ research product histor
perform inform certain addit disclosur concern ub research recommend pleas visit
www ub com/disclosur figur contain perform chart refer past past perform reliabl
indic futur result addit inform made avail upon request ub secur co limit licens
conduct secur invest consult busi china secur regulatori commiss ub act may act
princip debt secur relat deriv may subject report recommend
final octob gmt ub design certain research depart member deriv
research analyst depart member publish research princip analysi price market
deriv provid inform reason suffici upon base decis enter deriv
transact deriv research analyst co-author research report equiti research analyst economist
deriv research analyst respons deriv invest view forecast and/or recommend
analyst certif research analyst primarili respons content research report whole part
certifi respect secur issuer analyst cover report view express
accur reflect person view secur issuer prepar independ manner
includ respect ub part compens directli indirectli relat
specif recommend view express research analyst research report
fsr mra
fsr mra
fsr mra
stock price expect rise within three month time
rate assign specif catalyst event
stock price expect fall within three month time
rate assign specif catalyst event
ub rate alloc septemb
compani coverag global within rate categori
compani within rate categori invest bank ib servic provid
within past month
compani coverag global within short-term rate categori
compani within short-term rate categori invest bank ib servic provid
within past month
definit forecast stock return fsr defin expect percentag price appreci plu gross dividend
yield next month case yield may base accru dividend market return assumpt
mra defin one-year local market interest rate plu proxi forecast equiti risk
premium review ur stock may flag ur analyst indic stock price target and/or
rate subject possibl chang near term usual respons event may affect invest case
valuat short-term rate reflect expect near-term three month perform stock
reflect chang fundament view invest case equiti price target invest horizon
except special case uk european invest fund rate definit buy posit
factor structur manag perform record discount neutral neutral factor structur
manag perform record discount sell neg factor structur manag perform record
discount band except cbe except standard band may grant invest
review committe irc factor consid irc includ stock volatil credit spread respect
compani debt result stock deem high low risk may subject higher lower band
relat rate except appli identifi compani disclosur tabl relev
research analyst contribut report employ non-u affili ub secur llc
registered/qualifi research analyst finra analyst may associ person ub secur llc
therefor subject finra restrict commun subject compani public appear
trade secur held research analyst account name affili analyst employ affili
contribut report follow
